Catalyst Pharma Shares Halted Down 0.7% For Session; Stock Had Spiked As Much As 11% Earlier Following Trader Circulation Of Website Showing Approval For Co.'s Firdapse; Website Was Apparently Later Taken Down
Benzinga Newsdesk